A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...

Northwestern Medicine investigators have uncovered new insights into how intercellular "glue" functions to enable ...

Sub-Saharan Africa, home to 25 million of the world's 38 million people living with HIV, is expected to bear the brunt.

A research team led by Prof. Liu Xuanyong from the Shanghai Institute of Ceramics of the Chinese Academy of Sciences has ...

Named after Indiana teenager Ryan White – who contracted HIV in 1984 after receiving an untested blood transfusion while ...

A main obstacle to an HIV cure is that viral DNA integrates into the chromosomes of memory T cells (blue), which evade ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Switching to islatravir and doravirine was just as effective as bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC ...

For the majority of people with the virus in the U.S., dying with HIV has turned into living a long life with HIV.

In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...

In a ceremony held last month, the 2024 Louisa Gross Horwitz Prize was awarded to Wesley Sundquist, PhD, Leo T. and Barbara K ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...